Capital Impact Advisors, LLC 10x Genomics, Inc. Transaction History

Capital Impact Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$36.08 - $54.3 $371,443 - $559,018	-10,295 Reduced 43.63%	13,299 $499,000
Q4 2023 Feb 14, 2024	BUY	$34.32 - $57.55 $301,089 - $504,886	8,773 Added 59.19%	23,594 $1.32 Million
Q3 2023 Nov 14, 2023	BUY	$40.86 - $62.98 $348,780 - $537,597	8,536 Added 135.82%	14,821 $611,000
Q2 2023 Aug 14, 2023	SELL	$50.96 - $58.72 $18,855 - $21,726	-370 Reduced 5.56%	6,285 $350,000
Q1 2023 May 23, 2023	BUY	$35.33 - $55.79 $137,045 - $216,409	3,879 Added 139.73%	6,655 $371,000
Q4 2022 Feb 14, 2023	BUY	$24.4 - $41.3 $14,152 - $23,954	580 Added 26.41%	2,776 $101,000
Q3 2022 Nov 21, 2022	BUY	$28.48 - $52.59 $62,542 - $115,487	2,196 New	2,196 $82,000
Q4 2021 Feb 14, 2022	SELL	$135.05 - $182.59 $1.04 Million - $1.41 Million	-7,717 Closed	0 $0
Q2 2021 Aug 17, 2021	BUY	$134.22 - $202.37 $1.04 Million - $1.56 Million	7,717 New	7,717 $1.51 Million

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Impact Advisors, LLC with notifications on news.